Go to the list of all blogs
Sergey Savastiouk's Avatar
published in Blogs
Nov 01, 2026
TickeronGET DAILY SIGNALS
Charles Schwab (SCHW): Why the $120 Analyst Target Points to a +33% Upside

Charles Schwab (SCHW): Why the $120 Analyst Target Points to a +33% Upside

Key Takeaways

  • The central $120 stock price target represents a move of roughly 33–35% from recent trading levels near $89–90.
  • The target is the arithmetic mean of verified analyst price targets (approximately $118 across 24 analysts, per S&P Global), rounded to $120 for readability.
  • The analyst price target range is exceptionally wide — from $82 to $147 — reflecting genuine disagreement on Wall Street.
  • Bullish support comes from a record third quarter, raised revenue guidance, strong client asset growth, and elevated trading activity.
  • The biggest risks are cash-sorting uncertainty, sensitivity to interest rates, and a valuation overhang after a strong 2026 run.

Analyst Price Targets and Consensus View

The Charles Schwab Corporation (NYSE: SCHW) is a diversified financial-services company offering brokerage, wealth management, banking, and custody services. It is a stock, not an exchange-traded fund, so this analysis centers on individual analyst price targets. Across the roughly 24 analysts tracked by S&P Global, the average analyst price target sits near $118, with MarketBeat reporting a comparable average of about $120 and a range spanning $82 to $147. That unusually wide spread explains why treating any single figure as a guarantee would be misleading. Recent revisions capture the divergence: Morgan Stanley cut its target to $132, Deutsche Bank to $125, and TD Cowen maintained $129, while Wells Fargo trimmed to $103, BMO Capital to $97, and Bank of America — the notable bear — reduced its target to $82 with an Underperform rating. J.P. Morgan and several others sit near the top of the range. The reasoning behind the split is straightforward. Bullish analysts emphasize Schwab's record revenue, expanding net interest margin, and capital-return capacity. Cautious analysts focus on cash monetization, softer net interest income, and a less favorable risk-reward after the stock's 2026 rally. The rounded $120 central target reflects the broad consensus, not a single analyst's view. I also checked this using Tickeron’s AI Screener to see how the stock compares to others in the industry.

Current Market Position and Path Toward the Target

Schwab shares were recently trading near $89, having pulled back from a 52-week high of $114.53 set in August 2026. Reaching $120 would require a gain of roughly 33–35%, a substantial move that would also carry the stock above its prior 52-week high. That is not trivial, but it is consistent with the kind of appreciation analysts associate with a full-year earnings cycle. The path hinges on execution. Schwab delivered a strong third quarter, with EPS (earnings per share) rising about 28% year over year and revenue up roughly 17%. Management has raised its 2026 revenue-growth outlook to 17.5%–18.5%. At a P/E (price-to-earnings ratio) near 15 times trailing earnings, the stock trades below its historical median, leaving room for multiple expansion if earnings momentum continues and cash-sorting concerns ease.

What Could Support a Move Toward the Target

  • Earnings momentum: Record quarterly revenue and strong EPS growth support higher forward estimates; consensus sees 2027 EPS rising from about $6.44 to roughly $7.86.
  • Raised guidance: Management's upward revision to revenue growth signals confidence in operating leverage.
  • Client franchise: Schwab's scale in client assets, custody, and wealth management underpins recurring revenue.
  • Capital returns and rates: A stabilizing or modestly favorable rate backdrop supports net interest revenue and continued buybacks and dividends.
  • Valuation: A below-historical P/E offers room for upside if sentiment improves.

What Could Prevent the Target From Being Reached

  • Cash sorting: Clients shifting deposits into higher-yielding products remains a persistent drag on net interest income.
  • Rate sensitivity: Further Federal Reserve rate cuts would pressure the interest margin and net interest revenue.
  • Valuation skepticism: Bears such as Bank of America argue reduced visibility into long-term earnings limits upside.
  • Competition and disruption: Concerns about AI agents accessing customer accounts and fintech competition add uncertainty.
  • Technical resistance: The prior high near $114.53 stands as a meaningful hurdle below the $120 target.

Technical Levels and Market Structure

Schwab's long-term structure shows a 52-week range of roughly $83.96 to $114.53. The low near $84 has acted as durable support, while the $114–$115 area is the key resistance zone the stock must clear before approaching $120. The $100 level is a psychological midpoint. A decisive break above the prior high would signal renewed momentum; failure to hold the mid-$80s would suggest a deeper consolidation.

Time Horizon and What Investors Should Monitor

Analyst price targets generally reflect a research horizon of roughly 12 months, though individual firms vary. Investors should watch the next earnings report and guidance update, any revisions to analyst price targets, the trajectory of net interest margin and cash sorting, Federal Reserve rate decisions, and broader financial-sector sentiment. Changes to capital-return plans and client asset growth will also matter. From what I see, monitoring these factors closely helps frame the $120 target in context rather than as a fixed outcome.

Exploring AI Daily Buy/Sell Signals

In my own process, I often reference Tickeron’s AI Daily Buy/Sell Signals to track how SCHW fits into broader market patterns alongside other holdings. This tool applies artificial intelligence to scan thousands of stocks and ETFs, producing Buy, Sell, or Hold signals based on technical shifts and market conditions. It provides a structured layer of insight that complements traditional analyst targets without replacing them.

Final Assessment

The $120 target is best understood as a consensus-derived benchmark — the rounded average of roughly two dozen analyst price targets — not a foregone conclusion. It implies a substantial move of about a third from current levels and would require Schwab to eclipse its 52-week high. The case for getting there rests on durable earnings growth, raised guidance, and a strong client franchise, while the case against rests on cash-sorting pressures, rate sensitivity, and a wide $82-to-$147 analyst range that signals real disagreement. Investors should monitor earnings, guidance, rate policy, and analyst revisions rather than treat any single target as a certainty.

Disclaimer

The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.

Disclaimers and Limitations

Related Ticker: SCHW

Contributor

Sergey Savastiouk, Ph.D. has a degree in Applied Mathematics from Moscow University and has extensive experience as an entrepreneur, investor, manager, and mathematician. His professional expertise is in applied mathematics, mathematical modeling, system and pattern analysis, and software and hardware system integration. He has served as the CEO of several hi-tech start-up companies and nonprofit organizations, which has given him proven capabilities in business strategy for high-tech start-up companies, market assessment, company formation, team building, product development, marketing, and sales. He has published numerous articles in journals and magazines on related fields. As a retail investor, he spent 15 years developing his proprietary trading and quantitative algorithms (now Tickeron’s A.I.), which brought him significant returns in trading the stock market. His current work and goal in founding Tickeron is to bring professional, sophisticated stock market analysis capabilities to retail investors via an easy-to-use interface.


SCHW's RSI Indicator dives into oversold zone

The RSI Oscillator for SCHW moved into overbought territory on October 30, 2026. Be on the watch for a price drop or consolidation in the future -- when this happens, think about selling the stock or exploring put options.

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Stochastic Oscillator shows that the ticker has stayed in the oversold zone for 9 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an upward trend is expected.

Following a +2.30% 3-day Advance, the price is estimated to grow further. Considering data from situations where SCHW advanced for three days, in 185 of 320 cases, the price rose further within the following month. The odds of a continued upward trend are 58%.

SCHW may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

Bearish Trend Analysis

The Moving Average Convergence Divergence Histogram (MACD) for SCHW turned negative on October 15, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 48 similar instances when the indicator turned negative. In 29 of the 48 cases the stock turned lower in the days that followed. This puts the odds of success at 60%.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where SCHW declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 60%.

The Aroon Indicator for SCHW entered a downward trend on October 30, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Fundamental Analysis (Ratings)

The Tickeron SMR rating for this company is 5 (best 1 - 100 worst), indicating very strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Price Growth Rating for this company is 61 (best 1 - 100 worst), indicating steady price growth. SCHW’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is 70 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. SCHW’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 88, placing this stock better than average.

The Tickeron Seasonality Score of 75 (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.

The Tickeron PE Growth Rating for this company is 78 (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Valuation Rating of 88 (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (3.466) is normal, around the industry mean (3.108). P/E Ratio (15.951) is within average values for comparable stocks, (6.904). Projected Growth (PEG Ratio) (0.832) is also within normal values, averaging (0.809). Dividend Yield (0.015) settles around the average of (7.800) among similar stocks. P/S Ratio (7.148) is also within normal values, averaging (16.899).

Notable companies

The most notable companies in this group are Morgan Stanley (NYSE:MS), Goldman Sachs Group (NYSE:GS), Charles Schwab Corp (The) (NYSE:SCHW), Gold.com Inc. (NYSE:GOLD).

Industry description

These banks specialize in underwriting (helping companies with debt financing or equity issuances), IPOs, facilitating mergers and other corporate reorganizations and acting as a broker or financial advisor for institutions. They might also trade securities on their own accounts. Investment banks potentially thrive on expanding its network of clients, since that could help them increase profits. Goldman Sachs, Morgan Stanley and CME Group Inc are some of the largest investment banking companies.

Market Cap

The average market capitalization across the Investment Banks/Brokers Industry is 11.61B. The market cap for tickers in the group ranges from 590 to 289.46B. MS holds the highest valuation in this group at 289.46B. The lowest valued company is FSSLD at 590.

High and low price notable news

The average weekly price growth across all stocks in the Investment Banks/Brokers Industry was -7%. For the same Industry, the average monthly price growth was -21%, and the average quarterly price growth was -26%. IPST experienced the highest price growth at 29%, while AXG experienced the biggest fall at -82%.

Volume

The average weekly volume growth across all stocks in the Investment Banks/Brokers Industry was 68%. For the same stocks of the Industry, the average monthly volume growth was 55% and the average quarterly volume growth was -1%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 67
P/E Growth Rating: 66
Price Growth Rating: 69
SMR Rating: 74
Profit Risk Rating: 87
Seasonality Score: -1 (-100 ... +100)
View a ticker or compare two or three
SCHW
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
A.I. Advisor
published General Information

General Information

a provider of securities brokerage and other financial services

Industry InvestmentBanksBrokers

Industry
Investment Banks Or Brokers
Address
3000 Schwab Way
Phone
+1 817 859-5000
Employees
33000
Web
https://www.aboutschwab.com
Interact to see
Advertisement
The Bitwise Solana Staking ETF (BSOL) advanced roughly 18% over the trailing 30 days, closely tracking a sharp rally in Solana (SOL). The move extends a broader recovery, with BSOL up approximately 77% over the past three months from its mid-2026 trough.
MSTY is an actively managed single-stock option income ETF (exchange-traded fund) that writes call options on Strategy (MSTR), formerly MicroStrategy, to generate current income. The portfolio is anchored by U.S. Treasury bills and MSTR option contracts rather than a diversified basket of equities, concentrating exposure in one volatile underlying.
AMDL has surged roughly +64% over the past 30 days, from about $47.59 to $78.10, mirroring a powerful rally in its sole underlying stock, AMD . The fund is a leveraged single-stock ETF (exchange-traded fund) designed to deliver 2x the daily return of AMD, amplifying both gains and losses.
AstraZeneca reported Q1 2026 total revenue of $15.3 billion, up 8% at constant exchange rates (CER, adjusting for currency fluctuations), beating consensus estimates around $14.8 billion. Core earnings per share (EPS) rose 5% to $2.58 at CER, amid a 12% increase in core operating profit.
Consensus estimates call for Q3 FY2026 revenue of approximately $3.37 billion, in line with the company's guidance midpoint of $3.35 billion. Non-GAAP earnings per share (EPS) expected at $9.16, edging above the guided midpoint of $9.08.